Literature DB >> 33390748

Supplemental oxygen therapy recommendations in patients with sickle cell disease during air travel: A cross-sectional survey of North American health care providers.

Amarjot Padda1, Catherine Corriveau-Bourque1,2, Mark Belletrutti1,2, Aisha A K Bruce1,2.   

Abstract

INTRODUCTION: Air travel may expose patients with sickle cell disease (SCD) to an increased risk of disease-related complications. Several factors are felt to contribute including prolonged hypoxia, dehydration, temperature changes, and stress. The Canadian Paediatric Society (CPS) position statement, published in 2007, recommends that SCD patients use supplemental oxygen on flights. While the National Heart, Lung and Blood Institute (NHLBI) recommend that SCD patients dress warmly, stay hydrated, and move about the cabin. Other guidelines do not make specific recommendations.
METHODS: A cross-sectional online survey was circulated through the Canadian Hemoglobinopathy Association (CanHaem) and American Society of Pediatric Hematology and Oncology (ASPHO) listservs to North American health care practitioners (HCPs). Participants were asked to share their air travel recommendations for patients with SCD. Similarly, a patient survey regarding experiences with air travel was circulated through the Sickle Cell Disease Association of Canada (SCDAC) and the Sickle Cell Foundation of Alberta (SCFOA) listservs and discussion boards.
RESULTS: Although air travel is perceived to be a risk factor for sickling complications, only 18% of HCPs recommend supplemental oxygen. Most HCPs advise patients to increase hydration, carry analgesics, and wear warm clothes to prevent sickling complications. The patient survey was limited by a low response rate.
CONCLUSION: The majority of HCPs are not routinely recommending prophylactic oxygen to patients with SCD during air travel.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Air travel; Flight; Hemoglobinopathy; Oxygen; Sickle cell disease

Year:  2019        PMID: 33390748      PMCID: PMC7757762          DOI: 10.1093/pch/pxz049

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  28 in total

1.  Clinical triad of massive splenic infarction, sicklemia trait, and high altitude flying.

Authors:  J C COOLEY; W L PETERSON; C E ENGEL; J P JERNIGAN
Journal:  J Am Med Assoc       Date:  1954-01-09

Review 2.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

Review 3.  Classification of the disorders of hemoglobin.

Authors:  Bernard G Forget; H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

4.  Sickling crises and altitude. Occurrence in the Colorado patient population.

Authors:  B S Mahony; J H Githens
Journal:  Clin Pediatr (Phila)       Date:  1979-07       Impact factor: 1.168

5.  Definitions of the phenotypic manifestations of sickle cell disease.

Authors:  Samir K Ballas; Susan Lieff; Lennette J Benjamin; Carlton D Dampier; Matthew M Heeney; Carolyn Hoppe; Cage S Johnson; Zora R Rogers; Kim Smith-Whitley; Winfred C Wang; Marilyn J Telen
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

6.  The sickle-cell and altitude.

Authors:  R L Green; R G Huntsman; G R Serjeant
Journal:  Br Med J       Date:  1971-12-04

Review 7.  The effects of flight and altitude.

Authors:  M P Samuels
Journal:  Arch Dis Child       Date:  2004-05       Impact factor: 3.791

8.  Sickle cell children traveling abroad: primary risk is infection.

Authors:  Camille Runel-Belliard; Emmanuelle Lesprit; Béatrice Quinet; Emmanuel Grimprel
Journal:  J Travel Med       Date:  2009 Jul-Aug       Impact factor: 8.490

9.  Hydroxyurea for the treatment of sickle cell disease.

Authors:  M A el-Hazmi; A S Warsy; A al-Momen; M Harakati
Journal:  Acta Haematol       Date:  1992       Impact factor: 2.195

10.  Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000.

Authors:  Frédéric B Piel; Andrew J Tatem; Zhuojie Huang; Sunetra Gupta; Thomas N Williams; David J Weatherall
Journal:  Lancet Glob Health       Date:  2014-02       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.